Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.

Archives of pathology & laboratory medicine - 1 Nov 2002

Press Richard D, Bauer Kenneth A, Kujovich Jody L, Heit John A

Abstract excerpt

OBJECTIVE: To review the current state of the art regarding the role of the clinical laboratory in diagnostic testing for the factor V Leiden (FVL) thrombophilic mutation (and other protein C resistance disorders), and to generate, through literature reviews and opinions of recognized thought-leaders, expert consensus recommendations on methodology and diagnostic, prognostic, and management issues pertaining to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abortion, Habitual
Share to Blood Coagulation Tests

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Evidence-Based Medicine

Share to Factor V

Share to Practice Guidelines as Topic

Share to Pregnancy

Share to Thromboembolism

Share to Thrombophilia

Source

Identifiers

PMID: 12421138
DOI: 10.5858/2002-126-1304-CUOFVL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.PMID 12421138Read ↗

Diagnosis and management offactor V LeidenSemantic proximity Read ↗

Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.Semantic proximity Read ↗

Activated protein C resistance and factor V Leiden: a review.Semantic proximity Read ↗

Clinical and laboratory management of the prothrombin G20210A mutation.Semantic proximity Read ↗

Screening for thrombophilia: a laboratory perspective.Semantic proximity Read ↗

Thrombophilias--practical implications and testing caveats.Semantic proximity Read ↗

Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Semantic proximity Read ↗

Thrombophilias: when should we test and how does it help?Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Semantic proximity Read ↗

Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?Semantic proximity Read ↗

Clinical, Laboratory, and Molecular Aspects of Factor V DeficiencySemantic proximity Read ↗

Uncertain thrombophilia markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.